 | • レポートコード：MRC23Q36087 • 出版社/出版日：QYResearch / 2023年3月 • レポート形態：英文、PDF、61ページ • 納品方法：Eメール（2-3日） • 産業分類：医薬品 |
| Single User | ￥435,000 (USD2,900) | ▷ お問い合わせ |
| Enterprise License | ￥870,000 (USD5,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは世界のイロプロスト医薬品市場について調査・分析し、世界のイロプロスト医薬品市場概要、市場トレンド、主要企業別競争状況、タイプ別セグメント分析（吸入式、静脈注射式）、用途別セグメント分析（病院、診療所）、地域別市場規模、主要企業のプロファイルなどに関する情報を掲載しています。主要企業としては、Actelion (J & J)、Bayer AGなどが含まれています。 世界のイロプロスト医薬品市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争の影響は、イロプロスト医薬品市場規模を推定する際に考慮しました。本レポートは、イロプロスト医薬品の世界市場を定量的・定性的な分析により包括的に提示し、読者がビジネス/成長戦略を策定し、市場競争状況を把握し、現在の市場における自社のポジションを分析し、イロプロスト医薬品に関するビジネス上の意思決定に役立てることを目的としています。 ・イロプロスト医薬品市場の概要 - イロプロスト医薬品のタイプ別セグメント - 世界のイロプロスト医薬品市場規模：タイプ別分析（吸入式、静脈注射式） - イロプロスト医薬品の用途別セグメント - 世界のイロプロスト医薬品市場規模：用途別分析（病院、診療所） - 世界のイロプロスト医薬品市場規模予測（2018年-2029年） ・イロプロスト医薬品市場の成長トレンド - イロプロスト医薬品の地域別市場規模（2018年-2029年） - イロプロスト医薬品市場ダイナミクス - イロプロスト医薬品の業界動向 - イロプロスト医薬品市場の成長ドライバ、課題、阻害要因 ・主要企業別競争状況 - 企業別市場シェア - 世界の主要企業、業界ランキング分析 - 市場への参入、M＆A動向 ・タイプ別セグメント：吸入式、静脈注射式 - 世界のイロプロスト医薬品のタイプ別市場規模（2018年-2023年） - 世界のイロプロスト医薬品のタイプ別市場規模（2024年-2029年） ・用途別セグメント：病院、診療所 - 世界のイロプロスト医薬品の用途別市場規模（2018年-2023年） - 世界のイロプロスト医薬品の用途別市場規模（2024年-2029年） ・イロプロスト医薬品の地域別市場規模 - 北米のイロプロスト医薬品市場規模（2018年-2029年） - アメリカのイロプロスト医薬品市場規模（2018年-2029年） - ヨーロッパのイロプロスト医薬品市場規模（2018年-2029年） - アジア太平洋のイロプロスト医薬品市場規模（2018年-2029年） - 中国のイロプロスト医薬品市場規模（2018年-2029年） - 日本のイロプロスト医薬品市場規模（2018年-2029年） - 韓国のイロプロスト医薬品市場規模（2018年-2029年） - インドのイロプロスト医薬品市場規模（2018年-2029年） - オーストラリアのイロプロスト医薬品市場規模（2018年-2029年） - 中南米のイロプロスト医薬品市場規模（2018年-2029年） - 中東・アフリカのイロプロスト医薬品市場規模（2018年-2029年） ・主要企業のプロファイル：企業情報、事業概要、売上、動向 Actelion (J & J)、Bayer AG ・アナリストの観点/結論 ・調査方法とデータソース |
Iloprost is a drug used to treat pulmonary arterial hypertension (PAH), scleroderma, Raynaud’s phenomenon and other diseases in which the blood vessels are constricted and blood can’t flow to the tissues.
Highlights
The global Iloprost Drugs market was valued at US$ 88 million in 2022 and is anticipated to reach US$ 80 million by 2029, witnessing a CAGR of -1.6% during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North America is estimated to have a major share in the global market with 75%.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Iloprost Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Iloprost Drugs.
The Iloprost Drugs market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Iloprost Drugs market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Iloprost Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Actelion (J & J)
Bayer AG
Segment by Type
Inhaled
Intravenous
Segment by Application
Hospital
Clinic
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Iloprost Drugs companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Iloprost Drugs Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Inhaled
1.2.3 Intravenous
1.3 Market by Application
1.3.1 Global Iloprost Drugs Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Clinic
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Iloprost Drugs Market Perspective (2018-2029)
2.2 Iloprost Drugs Growth Trends by Region
2.2.1 Global Iloprost Drugs Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Iloprost Drugs Historic Market Size by Region (2018-2023)
2.2.3 Iloprost Drugs Forecasted Market Size by Region (2024-2029)
2.3 Iloprost Drugs Market Dynamics
2.3.1 Iloprost Drugs Industry Trends
2.3.2 Iloprost Drugs Market Drivers
2.3.3 Iloprost Drugs Market Challenges
2.3.4 Iloprost Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Iloprost Drugs Players by Revenue
3.1.1 Global Top Iloprost Drugs Players by Revenue (2018-2023)
3.1.2 Global Iloprost Drugs Revenue Market Share by Players (2018-2023)
3.2 Global Iloprost Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Iloprost Drugs Revenue
3.4 Global Iloprost Drugs Market Concentration Ratio
3.4.1 Global Iloprost Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Iloprost Drugs Revenue in 2022
3.5 Iloprost Drugs Key Players Head office and Area Served
3.6 Key Players Iloprost Drugs Product Solution and Service
3.7 Date of Enter into Iloprost Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Iloprost Drugs Breakdown Data by Type
4.1 Global Iloprost Drugs Historic Market Size by Type (2018-2023)
4.2 Global Iloprost Drugs Forecasted Market Size by Type (2024-2029)
5 Iloprost Drugs Breakdown Data by Application
5.1 Global Iloprost Drugs Historic Market Size by Application (2018-2023)
5.2 Global Iloprost Drugs Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Iloprost Drugs Market Size (2018-2029)
6.2 North America Iloprost Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Iloprost Drugs Market Size by Country (2018-2023)
6.4 North America Iloprost Drugs Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Iloprost Drugs Market Size (2018-2029)
7.2 Europe Iloprost Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Iloprost Drugs Market Size by Country (2018-2023)
7.4 Europe Iloprost Drugs Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Iloprost Drugs Market Size (2018-2029)
8.2 Asia-Pacific Iloprost Drugs Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Iloprost Drugs Market Size by Region (2018-2023)
8.4 Asia-Pacific Iloprost Drugs Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Iloprost Drugs Market Size (2018-2029)
9.2 Latin America Iloprost Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Iloprost Drugs Market Size by Country (2018-2023)
9.4 Latin America Iloprost Drugs Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Iloprost Drugs Market Size (2018-2029)
10.2 Middle East & Africa Iloprost Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Iloprost Drugs Market Size by Country (2018-2023)
10.4 Middle East & Africa Iloprost Drugs Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Actelion (J & J)
11.1.1 Actelion (J & J) Company Detail
11.1.2 Actelion (J & J) Business Overview
11.1.3 Actelion (J & J) Iloprost Drugs Introduction
11.1.4 Actelion (J & J) Revenue in Iloprost Drugs Business (2018-2023)
11.1.5 Actelion (J & J) Recent Development
11.2 Bayer AG
11.2.1 Bayer AG Company Detail
11.2.2 Bayer AG Business Overview
11.2.3 Bayer AG Iloprost Drugs Introduction
11.2.4 Bayer AG Revenue in Iloprost Drugs Business (2018-2023)
11.2.5 Bayer AG Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details